Header Logo

Connection

MITCHELL FREDERICK to Cyclin-Dependent Kinase Inhibitor p16

Back to Details
This is a "connection" page, showing publications MITCHELL FREDERICK has written about Cyclin-Dependent Kinase Inhibitor p16.
MITCHELL FREDERICK
Connection Strength
0.100
Cyclin-Dependent Kinase Inhibitor p16
  1. Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration. Mod Pathol. 2022 08; 35(8):1045-1054.
    View in: PubMed
    Score: 0.044
  2. CDKN2A/p16 Deletion in Head and Neck Cancer Cells Is Associated with CDK2 Activation, Replication Stress, and Vulnerability to CHK1 Inhibition. Cancer Res. 2018 02 01; 78(3):781-797.
    View in: PubMed
    Score: 0.033
  3. Lessons learned from next-generation sequencing in head and neck cancer. Head Neck. 2013 Mar; 35(3):454-63.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.